Patent · US Active

Epinephrine spray formulations

US10039710B2 · kind B2 · utility

23Cited by
2References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2017
Grant dateAug 7, 2018
Priority date
Expiry dateApr 17, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.